NovaBay Pharmaceuticals Receives NYSE Notice for Compliance

Seeking AlphaApr 22 13:43

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(ii) and (iii) of the NYSE American Company Guide pursuant to stockholders equity.

BusinesswireApr 20 06:00

NovaBay Pharmaceuticals Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Preliminary Q1 Net Revenue Results.

NovaBay Pharmaceuticals Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Preliminary Q1 Net Revenue Results.

BenzingaApr 17 19:50

NovaBay Pharmaceuticals Reports Preliminary Q1 FY24 Net Revenue For Its Eyecare And Wound Care Business Of $2.6M, Up 13% YoY

NovaBay Pharmaceuticals Reports Preliminary Q1 FY24 Net Revenue For Its Eyecare And Wound Care Business Of $2.6M, Up 13% YoY

BenzingaApr 17 19:01

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 27 23:28

Earnings Call Summary | NovaBay Pharmaceuticals(NBY.US) Q4 2023 Earnings Conference

The following is a summary of the NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript:Financial Performance:NovaBay reported a total Q4 2023 sales net of $3.7 million, marking a 2% in

Futu NewsMar 27 07:25 · Conference Call